Flexxon, a global leader in hardware-based cybersecurity and industrial NAND storage solutions, is proud to announce its new ...

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

INDIGO is the largest clinical trial conducted in patients living with IgG4-RD--Topline INDIGO results expected by the end of 2025-WALTHAM, ...

Security researchers from Perception Point have spotted a new two-step phishing campaign aiming to steal people’s Microsoft ...